While #oncology remains dominant, the rapid rise of GLP-1 therapies indicates how metabolic diseases are becoming a major focus of global #pharmaceutical innovation
You don't have to become a marathon runner to start making healthy choices
Schedule a free consultation to build your personalized GLP-1 + body contouring plan
Niche-independent high-purity cultures of Lgr5+ intestinal stem cells and their progeny
Preliminary data published in June 2023 also suggests that GLP-1 drugs 'could modulate crucial pathways in the pathogenesis of inflammatory bowel disease (IBD), such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity' (Arvanitakis, Theocharis, Popovic
But its stuck in comments in forums or on social media